Pharma Journalist - Page 833 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Artemis Therapeutics receives Orphan Drug Designation from FDA for Artemisone

STELARA (ustekinumab) shows positive results in treatment of Lupus in Phase 2 Trial

Stealth BioTherapeutics Initiates Phase 3 Study of Elamipretide in Patients with PMM

Boehringer Ingelheim and Dicerna to Develop Novel Treatments for Chronic Liver Diseases

Merck and CDRD Announce Joint Investment in the Canadian Life Sciences Ecosystem

Otsuka Announces Phase 3 Results for Tolvaptan in Patients with ADPKD

Preliminary Attendee List Announced for Pre-Filled Syringes Europe 2018

WuXi Biologics and Pall Corporation Establish Joint Continuous Bioprocess Laboratory

AstraZeneca provides update on tralokinumab Phase III programme in severe, uncontrolled asthma

FDA Grants Fast Track Designation to Visterra’s VIS410